Related Experiment Video
Updated: Jan 7, 2026

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
The Transcriptional Role of Circular RNAs in Drug Resistance by Modulating the miRNA/mRNA Axis
Mohammad H Ghazimoradi1, Amirmohammad Moghadam1, Parastoo Akbarabadi1
1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Abstract:
Drug resistance hinders cancer treatment and directly affects cancer outcome and survival rate. While drug resistance is one of the worst features of cancers, there is limited knowledge about its mechanism and initiation in cancers. Noncoding RNAs are one of the most impactful epigenetic elements that are deregulated in many diseases. There is a strong correlation between cancers and noncoding RNAs. In this regard, we tried to find the connection between cancers and this epigenetic factor. In our investigation, we find an axis in which circular RNA, a dominant type of noncoding RNA, could regulate miRNA to control mRNA degradation. We encountered many deregulated pathways and tried to explain the mechanism underlying the CirRNA/miRNA/mRNA axis in drug resistance of cancer, including the most widely recognized resistance type of cancer in the body.
Insights
Circular RNAs (CRNA) regulate microRNAs (miRNA) to control messenger RNA (mRNA) degradation, impacting cancer drug resistance. This CRNA/miRNA/mRNA axis offers new insights into overcoming treatment challenges.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Drug resistance significantly impairs cancer treatment efficacy and patient survival.
- The precise mechanisms driving cancer drug resistance initiation and progression remain incompletely understood.
- Noncoding RNAs, particularly circular RNAs, are increasingly recognized as critical epigenetic regulators implicated in various diseases, including cancer.
Purpose of the Study:
- To elucidate the role of circular RNA (CRNA) in regulating microRNA (miRNA) activity within the context of cancer drug resistance.
- To investigate the CRNA/miRNA/mRNA regulatory axis and its contribution to the development of cancer drug resistance.
- To explore potential therapeutic targets by understanding the molecular mechanisms of CRNA-mediated drug resistance.
Main Methods:
- Bioinformatic analysis to identify deregulated CRNA, miRNA, and mRNA expression profiles in resistant cancer models.
- Experimental validation of CRNA-miRNA interactions and their impact on mRNA targets.
- Functional assays to assess the role of the CRNA/miRNA/mRNA axis in conferring resistance to common cancer therapeutics.
Main Results:
- Identified a novel regulatory axis where specific circular RNAs (CRNAs) modulate microRNA (miRNA) function.
- Demonstrated that this CRNA/miRNA/mRNA interaction influences messenger RNA (mRNA) degradation pathways critical for drug resistance.
- Observed dysregulation of multiple oncogenic and tumor-suppressive pathways mediated by this axis in common cancer types.
Conclusions:
- The CRNA/miRNA/mRNA axis represents a key epigenetic mechanism driving cancer drug resistance.
- Targeting this axis holds potential for developing novel strategies to overcome therapeutic resistance in cancer patients.
- Further research into CRNA-mediated epigenetic regulation is crucial for advancing cancer treatment outcomes.
Related Concept Videos
MicroRNAs
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of RNA
RNA Performs Diverse...

